Evidence map›Paper›PMID 42755617›Full record

ArticleFrontiers in nephrology2026

Construction and evaluation of risk prediction model for major adverse cardiovascular events in peritoneal dialysis patients.

Jing Han, Xiaoli Guo, Xuejiao Liu, Jiping Sun, Fang Li, Yi Gao

Abstract read
In one paragraph

Article in Frontiers in nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jing HanDepartment of Nephrology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
Xiaoli GuoDepartment of Nephrology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
Xuejiao LiuDepartment of Nephrology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
Jiping SunDepartment of Nephrology, The First Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Fang Li *Department of Nephrology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China.
Yi Gao *Department of Nephrology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: This study developed and validated a robust, clinically applicable risk prediction model for cardiovascular mortality in high-risk peritoneal dialysis patients. The model enables precise individualized risk stratification, supports evidence-based clinical decisions, and facilitates targeted preventive interventions to improve long-term outcomes. Methods: A retrospective analysis was conducted on peritoneal dialysis patients at the Department of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, from June 2018 to May 2025. Cardiovascular disease served as the primary endpoint. Baseline characteristics and laboratory parameters were compared between groups. Univariate and multivariate regression analyses identified predictors of major adverse cardiovascular events. The predictive model was developed and validated using a 7:3 split after bootstrap resampling. Results: Multivariate analysis identified age, fasting blood glucose, absolute handgrip strength, and left ventricular ejection fraction as significant predictors. ROC curves (AUC > 0.6) and Kaplan-Meier curves (P < 0.05) confirmed their diagnostic and discriminatory value for major adverse cardiovascular events. A nomogram incorporating these four variables was developed. Its AUCs for predicting 3-, 5-, and 8-year cardiovascular event incidence were 0.828 (95% CI: 0.744-0.912), 0.785 (95% CI: 0.702-0.868), and 0.836 (95% CI: 0.744-0.929), respectively-indicating strong predictive discrimination. Using the optimal cut-off, patients were stratified into low- and high-risk groups. Kaplan-Meier analysis showed significant differences in cumulative event incidence at all three time points (P < 0.001), confirming good discrimination. Calibration demonstrated close agreement between predicted and observed outcomes; decision curve analysis supported robust clinical utility. Conclusion: Age, fasting blood glucose, absolute handgrip strength, and left ventricular ejection fraction are independent predictors of MACE in patients receiving PD. We have developed and internally validated a novel, interpretable nomogram-based risk prediction model that demonstrates high discriminative accuracy, calibration fidelity, and clinical utility. This tool holds substantial promise for early identification of high-risk individuals at PD initiation, thereby facilitating timely, personalized cardiovascular risk mitigation strategies.

Indexed as

cardiovascular diseasesend-stage renal diseasehandgrip strengthperitoneal dialysisprediction model

Identifiers

PMID42755617
PMCPMC13581586

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.